發表題目（編號PK3-25） 南臺灣某醫院門診腎移植患者之免疫抑制劑用藥趨勢分析 目的：分析南臺灣某醫院門診腎移植患者之免疫抑制劑2000~2010年用藥趨勢，是否與臨床試驗結果及治療準則一致。 方法：以2000~2010年門診健保申報資料進行分析，選用解剖治療化學分類代碼(ATC)、國際疾病診斷碼ICD-9 碼 (即V42.0)，以統計軟體SPSS 13.0英文版進行。 結果：門診腎移植患者於11年期間共開立51,397張處方，整體花費上升約4.9%~31.9%.，以Cyclosporine為主，可以清楚看見長期使用免疫抑制劑用藥趨勢變化，Tacrolimus與mycophenolic acid/ mycophenolate mofetil除使用率增加外，亦可見於合併藥物療程中。 結論：本研究可反映腎移植患者的用藥情況，尤其是長期使用calcineurin抑制劑或 corticosteroids的長期效益。 Trends in the use of immunosuppressive agents by outpatients after renal transplantation in a southern Taiwan hospital. Objectives Kidney transplantation has become an effective form of treatment for end-stage renal failure. This study analyzed trends in immunosuppressive agent use after renal transplantation follow up at a medical center in southern Taiwan over a 11-year period (2000–2010) and to determine whether the trends are consistent with clinical trial outcomes and published guidelines. Methods Consumption data were obtained via the health reimbursement claims data files of ambulatory care expenditure of the Kaohsiung Veterans General Hospital (VGHKS), a 1300 bed medical center for the period 2000-2010. Using Anatomical Therapeutic Chemical (ATC) classification codes we allocated to kidney replaced by transplant ICD-9 codes (i.e. V42.0). All the batch analysis was managed and performed using the SPSS version 13.0 for Windows in English version.